Brochure | July 7, 2022

BioReliance® Cell Banking And Storage

Cell bank development, characterization, and storage you can count on

BioReliance® cell banking professionals are experts at Cell Bank production for the biopharma industry. Our cGMP production facilities and extensive  technical and regulatory expertise provide the support you need for efficient product development to achieve regulatory approval.

Our scientists are experts in cGMP cell bank production and cell line characterization. Biosafety testing and characterization methods include sterility and mycoplasma testing, CO1 Barcode assay, in vitro and in vivo assays for adventitious viral contaminants, reverse transcription assays, antibody production assays, transmission electron microscopy, PCR and qPCR assays, bovine and porcine virus assays, and retroviral infectivity assays. A complete cell banking service, including pre- and postbank testing, is generally completed in about four months.

Our state-of-the-art, cGMP-compliant, controlled-access biorepository facilities are designed for short- and long-term storage of mammalian, insect, and bacterial cell lines in liquid nitrogen vapor (LN2) or ultra cold (-80oC) freezers. Each bank to be stored is certified free from mycoplasma and tested for sterility prior to storage. Each bank is divided and stored in separate validated freezers. Bi-continental storage of cell banks is also available.

access the Brochure!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Biosimilar Development? Subscribe today.

Subscribe to Biosimilar Development X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Biosimilar Development